Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells
Authors:
- 23 July 2020
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 73 (8) , 1520-1533
Abstract
Cancer stem cells (CSCs), a subgroup of cancer cells, have self-renewal capacity and differentiation potential and drive tumor growth. CSCs are highly-resistant to conventional chemo-radio therapy. Phytochemicals were shown to be able to eliminate CSCs. Phytol is a diterpene alcohol with demonstrated anticancer effects. The current study compared the effect of phytol with retinoic acid (RA) as a well-known inducers of CSC differentiation and cisplatin, a common chemotherapy drug, on CSC markers in human embryonic carcinoma NCCIT cells. NCCIT cells were exposed to 10 mM RA for 14 day to induce differentiation. Moreover, NCCIT cells were treated with IC50 dose of cisplatin (12 µM) and phytol (40 µM) for 7 day. Real-time PCR showed that phytol was more effective that RA and cisplatin in down-regulating the CSC markers OCT4, NANOG, SOX2, ALDH1, ABCB1, CD44 and CD133. Percentage of SP (13%) and ABCB1+ (0.34%) in NCCIT cells decreased to 7% and 0.1% respectively after treatment with phytol. A very small proportion of NCCIT cells were positive for CD44 (0.2%) and CD133 (0.48%) and this fraction did not change significantly after treatment with three agents. In conclusion, phytol has the greatest inhibitory effect on CSC population and markers than RA and cisplatin.Keywords
This publication has 76 references indexed in Scilit:
- Understanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacologica Sinica, 2013
- Mechanisms of chemoresistance in cancer stem cellsClinical and Translational Medicine, 2013
- Linking DNA Methyltransferases to Epigenetic Marks and Nucleosome Structure Genome-wide in Human Tumor CellsCell Reports, 2012
- Sox2 and Oct‐3/4: a versatile pair of master regulators that orchestrate the self‐renewal and pluripotency of embryonic stem cellsWIREs Mechanisms of Disease, 2009
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- Cancer stem cells and human malignant melanomaPigment Cell & Melanoma Research, 2008
- Epigenetic Reprogramming ofOCT4andNANOGRegulatory Regions by Embryonal Carcinoma Cell ExtractMolecular Biology of the Cell, 2007
- Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genesNucleic Acids Research, 2007
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997